Placebo group:Placebo for 12 weeks.
Sponsors
Peking University First Hospital
Conditions
Diabetic Peripheral Neuropathic Pain
Phase 2
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Parallel-designed Clinical Study to Evaluate the Efficacy and Safety of HL-1186 in Patients with Diabetic Peripheral Neuropathic Pain
Active, not recruitingChiCTR2500107621
Start: 2025-08-20Updated: 2025-08-18
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Parallel-designed Clinical Study to Evaluate the Efficacy and Safety of HL-1186 in Patients with Diabetic Peripheral Neuropathic Pain
RecruitingChiCTR2500109625
Start: 2025-08-22Updated: 2026-03-16